• Trevor Perrior
    Our medicinal chemists believe that 'every compound counts' - Dr Trevor Perrior, Research Director
    Every Compound Counts
  • Domainex is committed to the support of exciting and cutting-edge translational research
    Domainex is committed to the support of exciting and cutting-edge translational research
    Translational Research
  • Domainex applies unique technologies to overcome common drug discovery challenges
    Overcome Challenges
  • Domainex is developing an exciting pipeline of drugs that effect epigenetic targets
    Exciting Pipeline

Drug Discovery Services

Domainex's drug discovery CRO business reduces industry average project timelines by up to 30% through the application of novel proprietary technologies with a focussed, integrated approach to medicinal chemistry, biochemistry and computational chemistry.

Read more

Domainex's Discovery Pipeline

Domainex has applied its unique technologies and focussed discovery approach to enable it to develop its own pipeline of COPD and oncology drugs, including inhibitors of the kinases IKKε/TBK1 and protein lysine methyltransferases involved in epigenetics.

Read more

Events

28th April 2015
Babraham Institute, UK
11th May 2015
London
12th May to 13th May 2015
London

Contact Us

Get in contact to find out more about our services and pipeline!

  +44 (0) 1223 743170

  enquiries@domainex.co.uk